Tuberculin clinical trials
How each study uses Tuberculin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 20 Apr 1998 · Aplisol · BLA 103782 (FDA, Purple Book)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
Assiut University (2) · National Heart, Lung, and Blood Institute (NHLBI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Studies
Open first, then newest update. How each study uses Tuberculin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human LungCompletedEarly Phase 1National Heart, Lung, and Blood Institute (NHLBI)NCT05027958Written as Tuberculin Purified Protein Derivative
- Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common WartsStatus unknownPhase 3Assiut UniversityNCT04288817Written as Tuberculin purified protein derivative
- Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart PatientsStatus unknownPhase 3Assiut UniversityNCT03153566Written as tuberculin
- Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) InfectionCompletedNot applicableNational Institute of Allergy and Infectious Diseases (NIAID)NCT00000955Written as Tuberculin Purified Protein Derivative
Given beside what is tested · 2 — Tuberculin is usual care or a partner of the new treatment
- Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and AboveCompletedPhase 3Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.NCT05899179Written as Purified Protein Derivative of Tuberculin
- Leprosy Skin Test Antigens TrialCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00128193Written as Tuberculin, Purified Protein Derivative
As the comparator · 2 — what is tested is compared with Tuberculin
- A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)CompletedPhase 2Statens Serum InstitutNCT01241188Written as 2 TU Tuberculin PPD RT 23 SSI
- A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCGCompletedPhase 2Statens Serum InstitutNCT01242475Written as 2 TU Tuberculin PPD RT 23 SSI
Codes
What other systems call Tuberculin · ClinicalTrials.gg INT008374
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D014373 | Tuberculin | One source ClinicalTrials.gov |
| RxNorm | 8948 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.